Item 1.01. Entry into a Material Definitive Agreement.

Indemnification Agreements



In connection with the consummation of the Business Combination, New LanzaTech
entered into indemnification agreements with each of its directors and executive
officers. These indemnification agreements provide the directors and executive
officers with contractual rights to indemnification and the advancement of
certain expenses incurred by each such director or executive officer in any
action or proceeding arising out of his or her services as one of New
LanzaTech's directors or executive officers.

The foregoing description of the indemnification agreements does not purport to
be complete and is qualified in its entirety by the full text of the form of
indemnification agreement, a copy of which is attached hereto as Exhibit 10.29
and is incorporated herein by reference.

Registration Rights Agreement



At the Effective Time, AMCI, AMCI Sponsor II LLC (the "Sponsor"), Legacy
LanzaTech, and certain of the Legacy LanzaTech stockholders and AMCI
stockholders entered into a Registration Rights Agreement (the "Registration
Rights Agreement"), pursuant to which, among other things, such stockholders (i)
were granted certain registration rights with respect to certain securities held
by them, and (ii) are subject to certain restrictions on transfer with respect
to their shares of New LanzaTech Common Stock and New LanzaTech warrants.

Such restrictions will end (i) with respect to the Sponsor and the holders of
Class B common stock, on the earlier of (a) the date that is one year following
the Closing, (b) such date upon which the closing price per share of New
LanzaTech Common Stock equals or exceeds $12.00 per share for any 20 trading
days within any 30-day trading period commencing at least 150 days after the
Closing and (c) the date on which New LanzaTech completes a

                                       5
--------------------------------------------------------------------------------

liquidation, merger, capital stock exchange, reorganization or other similar
transaction after the Business Combination that results in all of New
LanzaTech's stockholders having the right to exchange their shares of New
LanzaTech Common Stock for cash, securities or other property, and (ii) with
respect to the holders of shares of Legacy LanzaTech capital stock, on the date
that is six months following the Closing.
. . .


Item 2.01. Completion of Acquisition or Disposition of Assets.



Reference is made to the disclosure described in the "Introductory Note" of this
Current Report on Form 8-K (this "Current Report"), which is incorporated herein
by reference.

FORM 10 INFORMATION

Item 2.01(f) of Form 8-K states that if the predecessor registrant was a "shell
company" (as such term is defined in Rule 12b-2 under the Securities Exchange
Act of 1934, as amended (the "Exchange Act")), as AMCI was immediately before
the Business Combination, then the registrant must disclose the information that
would be required if the registrant were filing a general form for registration
of securities on Form 10. As a result of the consummation of the Business
Combination, and as discussed below in Item 5.06 of this Current Report, New
LanzaTech has ceased to be a shell company. Accordingly, New LanzaTech is
providing the information below that would be included in a Form 10 if New
LanzaTech were to file a Form 10. Please note that the information provided
below relates to New LanzaTech as the combined company after the consummation of
the Business Combination, unless otherwise specifically indicated or the context
otherwise requires.

                                       6
--------------------------------------------------------------------------------

Forward-Looking Statements



This Current Report contains statements that are forward-looking and as such are
not historical facts. This includes, without limitation, statements regarding
the financial position, business strategy and the plans and objectives of
management for future operations. These statements constitute projections,
forecasts and forward-looking statements, and are not guarantees of performance.
Such statements can be identified by the fact that they do not relate strictly
to historical or current facts. When used in this Current Report, words such as
"anticipate," "believe," "continue," "could," "estimate," "expect," "intend,"
"may," "might," "plan," "possible," "potential," "predict," "project," "should,"
"strive," "would" and similar expressions may identify forward-looking
statements, but the absence of these words does not mean that a statement is not
forward-looking. When we discuss our strategies or plans, we are making
projections, forecasts or forward-looking statements. Such statements are based
. . .


Item 3.02. Unregistered Sales of Equity Securities



In connection with the Closing, AMCI consummated the Private Placement.
Reference is made to the disclosure under the heading "Introductory Note" of
this Current Report, which is incorporated herein by reference. The shares of
common stock issued pursuant to the Subscription Agreements have not been
registered under the Securities Act of 1933, as amended (the "Securities Act"),
and were issued in reliance upon the exemption provided under Section 4(a)(2) of
the Securities Act and Regulation D promulgated thereunder.

On January 29, 2021, the Sponsor subscribed for an aggregate of 5,031,250 shares
of AMCI Class B common stock, par value $0.0001 per share (the "Founder Shares")
for a total subscription price of $25,000, or approximately $0.005 per share. In
March 2021, the Sponsor transferred all of the Founder Shares held by it to
members of AMCI's board of directors, its management team and persons or
entities affiliated with AMCI Group. On May 14, 2021, certain of AMCI's initial
stockholders forfeited an aggregate of 718,750 Founder Shares, resulting in an
aggregate of 4,312,500 Founder Shares outstanding. On September 17, 2021, the
over-allotment option expired and therefore, the initial stockholders forfeited
562,500 Founder Shares, resulting in an aggregate of 3,750,000 Founder Shares
outstanding.

Simultaneous with the consummation of AMCI's Initial Public Offering, the
Sponsor purchased 3,500,000 Private Placement Warrants at a price of $1.00 per
Private Placement Warrant, generating gross proceeds of $3.5 million. No
underwriting discounts or commissions were paid with respect to such sales. This
issuance was made pursuant to the exemption from registration contained in
Section 4(a)(2) of the Securities Act.

                                       40
--------------------------------------------------------------------------------

On February 8, 2023, pursuant to certain non-redemption agreements dated February 3, 2023 and February 6, 2023, AMCI issued and sold 1,250,000 shares of AMCI Class A common stock to certain qualified institutional buyers and accredited investors.

On February 8, 2023 AMCI issued and sold 469,052 shares of AMCI Class A common stock to certain anchor investors.



Upon the Closing, unvested options to purchase an aggregate of 3,271,104 shares
of Legacy LanzaTech common stock at exercise prices between approximately $0.70
. . .


Item 3.03. Material Modifications to Rights of Security Holders.



In connection with the consummation of the Business Combination, AMCI changed
its name to "LanzaTech Global, Inc." and adopted the Second Amended and Restated
Certificate of Incorporation (the "Charter"). Reference is made to the sections
of the Proxy Statement/Prospectus entitled "The Charter Proposal," "The Advisory
Charter Amendment Proposals," "Comparison of Stockholders' Rights" and
"Description of New LanzaTech's Securities After the Business Combination"
beginning on pages 179, 181, 289 and 276 of the Proxy Statement/Prospectus,
respectively, which are incorporated herein by reference. This summary is
qualified in its entirety by reference to the text of the Charter and the bylaws
of New LanzaTech, which are attached as Exhibits 3.1 and 3.2 hereto,
respectively, and which are incorporated herein by reference.


Item 4.01. Change in the Registrant's Certifying Accountant.



On February 8, 2023, the Board approved a resolution appointing Deloitte &
Touche, LLP ("Deloitte") as New LanzaTech's independent registered public
accounting firm to audit New LanzaTech's consolidated financial statements for
the fiscal year ending December 31, 2023. Deloitte served as the independent
registered public accounting firm of Legacy LanzaTech prior to the Business
Combination. Accordingly, Marcum LLP ("Marcum"), AMCI's independent registered
public accounting firm prior to the Business Combination, was informed on
February 8, 2023 that it will be dismissed as New LanzaTech's independent
registered public accounting firm, effective upon completion of Marcum's audit
of AMCI's consolidated financial statements as of and for the year ended
December 31, 2022, and the issuance of their report thereon.

The report of Marcum on AMCI's financial statements as of and for the most
recent fiscal year ended December 31, 2021 did not contain an adverse opinion or
a disclaimer of opinion, and were not qualified or modified as to uncertainties,
audit scope or accounting principles, except that such report contained an
explanatory paragraph which noted that there was substantial doubt as to AMCI's
ability to continue as a going concern because AMCI's cash and working capital
as of December 31, 2021, were not sufficient to complete its planned activities
for a reasonable period of time.

During AMCI's fiscal year ended December 31, 2021 and the subsequent interim
periods through September 30, 2022, there were no disagreements between AMCI and
Marcum on any matter of accounting principles or practices, financial disclosure
or auditing scope or procedure, which disagreements, if not resolved to the
satisfaction of

                                       41
--------------------------------------------------------------------------------

Marcum, would have caused it to make reference to the subject matter of the disagreements in its reports on AMCI's financial statements for such year.



During AMCI's fiscal year ended December 31, 2021 and the subsequent interim
period through September 30, 2022, there were no "reportable events" (as defined
in Item 304(a)(1)(v) of Regulation S-K ("Regulation S-K") under the Exchange
Act), except that Marcum advised AMCI of material weaknesses related to: (i) the
accounting for certain complex financial instruments and (ii) the accounting of
certain fees related to financial advisory and placement agent services.

New LanzaTech provided Marcum with a copy of the foregoing disclosures and has . . .

Item 5.01. Changes in Control of Registrant.



Reference is made to the section of the Proxy Statement/Prospectus entitled "The
Business Combination Proposal-Structure of the Merger Agreement," beginning on
page 120 of the Proxy Statement/Prospectus, which is incorporated herein by
reference. Further reference is made to disclosure in the section entitled
"Introductory Note" and in Item 2.01 of this Current Report, which is
incorporated herein by reference.


Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Board of Directors



Upon the consummation of the Business Combination, each director of AMCI and
each executive officer of AMCI ceased serving in such capacities, and seven new
directors were elected to the Board. The Board was divided into three staggered
classes of directors and each director was assigned to one of the three classes.
At each annual meeting of the stockholders of New LanzaTech, a class of
directors will be elected for a three-year term to succeed the directors of the
same class whose terms are then expiring. The Board consists of the following
directors:

•Three Class I directors: Nigel Gormly, Jennifer Holmgren and Nimesh Patel.

•Two Class II directors: Barbara Byrne and Gary Rieschel.

•Two Class III directors: Jim Messina and Dorri McWhorter.

Dr. Holmgren serves as chair of the Board. The primary responsibilities of the
Board are to provide risk oversight and strategic guidance to New LanzaTech and
to counsel and direct New LanzaTech's management. The Board will meet on a
regular basis and will convene additional meetings, as required.

Furthermore, effective as of the Effective Time, the Board established three
standing committees: an audit committee, a nominating and governance committee,
and a compensation committee. The members of the audit committee are Barbara
Byrne, Nigel Gormly and Dorri McWhorter, and Ms. McWhorter chairs the audit
committee. The members of the nominating and governance committee are Nigel
Gormly, Dorri McWhorter and Jim Messina, and Mr. Messina chairs the nominating
and governance committee. The members of the compensation committee are Barbara
Byrne, Jim Messina and Gary Rieschel, and Mr. Rieschel chairs the compensation
committee.

                                       42
--------------------------------------------------------------------------------

Reference is made to the description of the compensation of the directors of
Legacy LanzaTech and of AMCI before the consummation of the Business Combination
described in the Proxy Statement/Prospectus in the sections entitled
"LanzaTech's Executive and Director Compensation-Non-Employee Director
Compensation" and "Other Information About AMCI-Executive Compensation and
Director Compensation," beginning on pages 289 and 194 of the Proxy
Statement/Prospectus, respectively, which are incorporated herein by reference.

New LanzaTech's executive compensation program is designed to align compensation
with business objectives and the creation of stockholder value, while enabling
New LanzaTech to attract, retain, incentivize and reward individuals who
contribute to its long-term success. Decisions regarding the executive
compensation program are made by the compensation committee of the Board.

Independence of Directors

New LanzaTech adheres to the rules of Nasdaq in determining whether a director . . .

Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.



On the Closing Date, New LanzaTech amended and restated its existing amended and
restated certificate of incorporation (the "Charter"). A copy of the Charter is
attached as Exhibit 3.1 hereto and is incorporated herein by reference.

Reference is made to the disclosure regarding the material changes to the
Charter and the rights of New LanzaTech's stockholders set forth therein in the
sections of the Proxy Statement/Prospectus entitled "The Charter Proposal,"
"Description of New LanzaTech's Securities After the Business Combination" and
"Comparison of Stockholders' Rights," beginning on pages 179, 276 and 289 of the
Proxy Statement/Prospectus, respectively, which are incorporated herein by
reference.


Item 5.05 Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics



On February 8, 2023, the Board adopted a new Code of Conduct and Ethics that
applies to all of its employees, officers and directors, including its Chief
Executive Officer, Chief Financial Officer and other executive and senior
financial officers. The full text of New LanzaTech's Code of Conduct and Ethics
is available on our website at
https://ir.lanzatech.com/corporate-governance/documents-charters.

The adoption of the Code of Conduct and Ethics did not relate to or result in
any waiver, explicit or implicit, of any provision of AMCI's Code of Conduct.
Any waivers under the Code of Conduct and Ethics will be disclosed on a Current
Report on Form 8-K or as otherwise permitted by the rules of the SEC and Nasdaq
(or other stock exchange on which New LanzaTech securities are then listed).


Item 5.06. Change in Shell Company Status.



As a result of the Business Combination, AMCI ceased to be a shell company upon
the Closing. The material terms of the Business Combination are described in the
section of the Proxy Statement/Prospectus entitled "The Business Combination
Proposal," beginning on page 120 of the Proxy Statement/Prospectus, and are
incorporated herein by reference.

                                       45
--------------------------------------------------------------------------------

Item 7.01. Regulation FD Disclosure.



On February 9, 2023, New LanzaTech issued a press release announcing the
consummation of the Business Combination. Reference is made to such press
release, which is furnished as Exhibit 99.3 hereto and is incorporated herein by
reference. The foregoing (including Exhibit 99.3) is being furnished pursuant to
Item 7.01 and will not be deemed to be filed for purposes of Section 18 of the
Exchange Act, or otherwise be subject to the liabilities of that section, nor
will it be deemed to be incorporated by reference in any filing under the
Securities Act or the Exchange Act.


Item 9.01. Financial Statements and Exhibits.

(a)Financial statements of businesses acquired.

Information responsive to Item 9.01(a) of Form 8-k is set forth in the financial statements included in the Proxy Statement/Prospectus on pages F-46 through F-102, and is incorporated herein by reference.

(b)Pro forma financial information.



The unaudited pro forma condensed combined financial information of New
LanzaTech as of September 30, 2022, and for the year ended December 31, 2021,
and the nine months ended September 30, 2022, is attached as Exhibit 99.2 to
this Report and incorporated herein by reference.

                                       46
--------------------------------------------------------------------------------


(d)Exhibits

Exhibit
Number                                                    Description
2.1*†                   Merger Agreement, dated as of March 8, 2022, by

and among AMCI, AMCI Merger Sub,


                      Inc., and LanzaTech NZ, Inc. (incorporated by 

reference to Exhibit 2.1 to LanzaTech

Global, Inc.'s Registration Statement on S-4/A, filed 

with the SEC on January 9,


                      2023).
2.2*                    Amendment No. 1 to Merger Agreement, dated as of 

December 7, 2022, by and among

AMCI Acquisition Corp. II, AMCI Merger Sub, Inc. and 

LanzaTech NZ, Inc.


                      (incorporated by reference to Exhibit 2.2 to 

LanzaTech Global, Inc.'s Registration


                      Statement on S-4/A, filed with the SEC on January 9, 

2023).


3.1                     Second Amended and Restated Certificate of 

Incorporation of LanzaTech Global,


                      Inc.
3.2                     Bylaws of LanzaTech Global, Inc.
4.1*                    Warrant Agreement, dated as of August 3, 2021, 

between AMCI Acquisition Corp. II


                      and Continental Stock Transfer & Trust Company

(incorporated by reference to Exhibit


                      4.1 LanzaTech Global, Inc.'s Registration Statement 

on S-4/A, filed with the SEC on

January 9, 2023).
4.2                     SAFE Warrant, dated as of December 7, 2021, from 

LanzaTech NZ, Inc. to


                      ArcelorMittal XCarb S.à r.l.
4.3†                    Assignment and Novation Agreement, dated February 

3, 2023, by and among AMCI

Acquisition Corp. II, LanzaTech NZ, Inc., ACM ARRT 

H LLC, and


                      Vellar    Opportunity Fund SPV LLC - Series 10.
10.1*                   Form of Initial Subscription Agreement 

(incorporated by reference to Exhibit 10.1


                      to LanzaTech Global, Inc.'s Registration Statement on 

S-4/A, filed with the SEC on

January 9, 2023).
10.1.1*†                Form of Amendment and Consent of Initial PIPE 

Investors (incorporated by reference


                      to Exhibit 10.1.1 to LanzaTech Global, Inc.'s

Registration Statement on S-4/A, filed


                      with the SEC on January 9, 2023).
10.2+                   LanzaTech 2023 Long-Term Incentive Plan.
10.2.1*+                Form of Stock Option Agreement under LanzaTech 2023 

Long-Term Incentive Plan


                      (incorporated by reference to Exhibit 10.4.1 to 

LanzaTech Global, Inc.'s


                      Registration Statement on S-4/A, filed with the SEC on January 9, 2023).
10.2.2*+                Form of Time-Vested Restricted Stock Unit Agreement 

under the LanzaTech 2023


                      Long-Term Incentive Plan (incorporated by reference 

to Exhibit 10.4.2 to LanzaTech

Global, Inc.'s Registration Statement on S-4/A, filed 

with the SEC on January 9,


                      2023).
10.2.3*+                Form of Director Restricted Stock Unit Agreement 

under the LanzaTech 2023


                      Long-Term Incentive Plan (incorporated by reference 

to Exhibit 10.4.3 to LanzaTech

Global, Inc.'s Registration Statement on S-4/A, filed 

with the SEC on January 9,


                      2023).
10.2.4*+                Form of Time- and Performance-Vested Restricted 

Stock Unit Agreement under the

LanzaTech 2023 Long-Term Incentive Plan (incorporated 

by reference to Exhibit 10.4.4


                      to LanzaTech Global, Inc.'s Registration Statement on 

S-4/A, filed with the SEC on

January 9, 2023).
10.3*†                  Registration Rights Agreement (included in Exhibit 2.1).
10.4*                   Form of Lock-up Agreement (incorporated by 

reference to Exhibit 10.7 to LanzaTech

Global, Inc.'s Registration Statement on S-4/A, filed 

with the SEC on January 9,


                      2023).
10.5*                   Exclusive Patent License Agreement, dated September 

13, 2018, by and between

Battelle Memorial Institute and LanzaTech, Inc.

(incorporated by reference to


                      Exhibit 10.12 to LanzaTech Global, Inc.'s

Registration Statement on S-4/A, filed


                      with the SEC on January 9, 2023)
10.5.1*#                Letter Amendment 1, dated January 13, 2020, between 

Battelle Memorial Institute


                      and LanzaTech, Inc. (incorporated by reference to 

Exhibit 10.12.1 to LanzaTech

Global, Inc.'s Registration Statement on S-4/A, filed 

with the SEC on January 9,


                      2023)
10.5.2*#                Clarification Letter, dated April 24, 2020, between 

Battelle Memorial Institute


                      and LanzaTech, Inc. (incorporated by reference to 

Exhibit 10.12.2 to LanzaTech

Global, Inc.'s Registration Statement on S-4/A, filed 

with the SEC on January 9,


                      2023)
10.6*†#                 Amended and Restated Investment Agreement, dated 

April 2, 2021, by and among

LanzaTech, Inc., LanzaJet, Inc., Mitsui & Co., Ltd., 

Suncor Energy Inc., British

Airways PLC and Shell Ventures LLC. (incorporated by 

reference to Exhibit 10.13 to

LanzaTech Global, Inc.'s Registration Statement on 

S-4/A, filed with the SEC on

January 9, 2023)


                                       47
--------------------------------------------------------------------------------

10.7*†#                 Intellectual Property and Technology License 

Agreement, dated May 28, 2020,


                      between LanzaTech, Inc. and LanzaJet, Inc.

(incorporated by reference to Exhibit


                      10.14 to LanzaTech Global, Inc.'s Registration 

Statement on S-4/A, filed with


                      the SEC on January 9, 2023)
10.8*†#                 Amended and Restated Stockholders' Agreement, 

dated April 2, 2021, by and


                      among LanzaJet, Inc., LanzaTech, Inc., Mitsui & Co., 

Ltd., Suncor Energy Inc.,

British Airways PLC, and Shell Ventures LLC. 

(incorporated by reference to


                      Exhibit 10.15 to LanzaTech Global, Inc.'s

Registration Statement on S-4/A, filed


                      with the SEC on January 9, 2023)
10.9*#                  Amended and Restated Alliance Agreement, dated 

February 15, 2022, by and


                      between LanzaTech NZ, Inc. and Mitsui & Co., Ltd. 

(incorporated by reference to


                      Exhibit 10.16 to LanzaTech Global, Inc.'s

Registration Statement on S-4/A, filed


                      with the SEC on January 9, 2023)
10.9.1*#                Amendment No. 1 to Amended and Restated Alliance

Agreement, dated March 24,


                      2022, by and between LanzaTech NZ, Inc. and Mitsui & 

Co., Ltd. (incorporated by


                      reference to Exhibit 10.16.1 to LanzaTech Global, 

Inc.'s Registration Statement


                      on S-4/A, filed with the SEC on January 9, 2023)
10.9.2*#                Amendment No. 2 to Amended and Restated Alliance

Agreement, dated October 2,


                      2022, by and between LanzaTech NZ, Inc. and Mitsui & 

Co., Ltd (incorporated by


                      reference to Exhibit 10.16.2 to LanzaTech Global, 

Inc.'s Registration Statement


                      on S-4/A, filed with the SEC on January 9, 2023)
10.10*#                 Articles of Association of Beijing Shougang

LanzaTech Technology Co., Ltd.


                      (incorporated by reference to Exhibit 10.17 to 

LanzaTech Global, Inc.'s


                      Registration Statement on S-4/A, filed with the SEC on January 9, 2023)
10.11*                  Side Letter Agreement, dated November 3, 2021, by 

and among Beijing Shougang

LanzaTech Technology Co., Ltd., Mitsui & Co., Ltd., 

and LanzaTech Hong Kong


                      Limited (incorporated by reference to Exhibit 10.18 

to LanzaTech Global, Inc.'s


                      Registration Statement on S-4/A, filed with the SEC on January 9, 2023)
10.12*#                 2021 Intellectual Property Rights License 

Agreement, dated September 6, 2021,


                      between Beijing Shougang LanzaTech Technology Co., 

Ltd. and LanzaTech Hong Kong


                      Limited     (incorporated by reference to Exhibit 

10.19 to LanzaTech Global,


                      Inc.'s Registration Statement on S-4/A, filed with the SEC on January 9, 2023)
10.12.1*                Amendment No. 1 to 2021 Intellectual Property 

License Agreement, dated January


                      14, 2022, between Beijing Shougang LanzaTech 

Technology Co., Ltd. and LanzaTech

Hong Kong Limited (incorporated by reference to 

Exhibit 10.19.1 to LanzaTech

Global, Inc.'s Registration Statement on S-4/A, filed 

with the SEC on January 9,


                      2023).
10.13*#                 Letter Agreement, dated April 12, 2021, among 

LanzaTech New Zealand Limited,

LanzaTech Hong Kong Limited, Sinopec Capital Co, Ltd

and Beijing

Shougang-LanzaTech Technology Co., Ltd. (incorporated 

by reference to Exhibit


                      10.20 to LanzaTech Global, Inc.'s Registration 

Statement on S-4/A, filed with


                      the SEC on January 9, 2023).
10.14*†#                Grant Agreement, dated October 7, 2020, among the 

European Climate,

Infrastructure and Environmental Executive Agency, 

SkyNRG BV, RSB Roundtable on

Sustainable Biomaterials Association, LanzaTech BV, E4tech UK Ltd, and
                      Fraunhofer Gesellschaft zur Forderung der Angewandten Forschung E.V.
                      (incorporated by reference to Exhibit 10.21 to

LanzaTech Global, Inc.'s


                      Registration Statement on S-4/A, filed with the SEC on January 9, 2023).
10.15*#                 Memorandum of Understanding, dated June 20, 2018, 

between Sekisui Chemical


                      Co., Ltd. and LanzaTech, Inc. (incorporated by 

reference to Exhibit 10.22 to

LanzaTech Global, Inc.'s Registration Statement on 

S-4/A, filed with the SEC on

January 9, 2023).
10.16*#                 Term Sheet, dated February 21, 2020, between 

Sekisui Chemical Co., Ltd. and

LanzaTech, Inc. (incorporated by reference to Exhibit 

10.23 to LanzaTech Global,


                      Inc.'s Registration Statement on S-4/A, filed with 

the SEC on January 9,


                      2023).
10.17*#                 Letter of Agreement, dated December 4, 2017, 

between LanzaTech, Inc. and

IndianOil Corporation Limited (incorporated by 

reference to Exhibit 10.24 to

LanzaTech Global, Inc.'s Registration Statement on 

S-4/A, filed with the SEC on

January 9, 2023).
10.18*#                 Master Licensing Agreement, dated October 6, 2020, 

between Suncor Energy Inc.


                      and LanzaTech, Inc. (incorporated by reference to 

Exhibit 10.25 to LanzaTech

Global, Inc.'s Registration Statement on S-4/A, filed 

with the SEC on January 9,


                      2023).
10.18.1*                Amendment No. 1 to Master Licensing Agreement, 

dated October 2, 2022, between


                      Suncor Energy Inc. and LanzaTech, Inc. (incorporated by reference to Exhibit
. . .

© Edgar Online, source Glimpses